SYBX News and Press, Synlogic Inc. From 02/09/24

2024-02-09 11:58:34 ET More on Synlogic Synlogic to discontinue lead drug program, cease operations Synlogic provides corporate update, outlook for 2024 Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial in...

2024-02-09 10:00:22 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...

2024-02-09 08:45:19 ET Losers: Synlogic ( SYBX ) -54% announces decision to discontinue synpheny-3 study and provides corporate update . Childrens Place ( PLCE ) -48% after posting weak guidance, updating on efforts to find new financing. BioXcel Therapeuti...

2024-02-08 16:48:45 ET More on Synlogic Synlogic provides corporate update, outlook for 2024 Synlogic bags contract to develop live probiotic products Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial info...

Decision to end trial follows internal review of initial data indicating study unlikely to meet primary endpoint Data review found treatment to be safe and well-tolerated Board of Directors plans to perform assessment of strategic options CAMBRIDGE, Mass., Feb. 08, 2024 (GLO...

Findings support positive proof of mechanism, through successful degradation of methionine, precursor to homocysteine, using dietary disease model in preclinical models and healthy volunteer study SYNB1353 was well-tolerated, with similar proportions in both the placebo and active arms ...

NEW YORK, NY / ACCESSWIRE / January 16, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking place Wednesday and Thursday, January 17-18, 2024. The presentation schedule is su...

2024-01-04 09:43:01 ET More on Synlogic Synlogic bags contract to develop live probiotic products Synlogic earns $2.5 million milestone payment from Roche collaboration Seeking Alpha’s Quant Rating on Synlogic For further details see: Synlogic prov...

- Data review from pivotal Synpheny-3 study in PKU expected in H1 2024, with potential to expand study population to patients aged 12-17 years of age - - Top-line, Phase 3 data in PKU expected in H1 2025 - CAMBRIDGE, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: S...

2023-12-27 08:02:38 ET More on Synlogic Synlogic earns $2.5 million milestone payment from Roche collaboration Synlogic down 4%, priced $21M offering Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial infor...